IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 136 filers reported holding IMMUNOMEDICS INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $48,297,000 | +150.8% | 567,996 | +4.5% | 0.40% | +82.7% |
| Q2 2020 | $19,254,000 | +730.3% | 543,288 | +395.7% | 0.22% | +388.9% |
| Q4 2019 | $2,319,000 | +4.7% | 109,597 | -31.4% | 0.04% | -26.2% |
| Q2 2019 | $2,215,000 | -8.1% | 159,677 | +37.9% | 0.06% | +15.1% |
| Q3 2018 | $2,411,000 | -21.9% | 115,766 | -11.3% | 0.05% | -36.1% |
| Q2 2018 | $3,089,000 | -27.4% | 130,495 | -57.1% | 0.08% | -12.6% |
| Q3 2017 | $4,252,000 | +556.2% | 304,184 | +314.4% | 0.10% | +493.8% |
| Q2 2017 | $648,000 | -50.4% | 73,397 | -63.6% | 0.02% | -50.0% |
| Q1 2017 | $1,306,000 | – | 201,870 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
| J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
| Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
| SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
| J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |